INDEBTEDNESS

Total borrowings consist of the following obligations:



(In millions)	September 7, 2013		December 29, 2012		September 8, 2012
Term Loan A, due October 9, 2017	$	529.4	$	550.0	$	—
Term Loan B, due October 9, 2019	237.7		325.0		—
Senior notes, 6.125% interest, due October 15, 2020	375.0		375.0		—
Borrowings under Revolving Credit Facility (1)	—		—		27.0
Total interest-bearing debt	1,142.1		1,250.0		27.0
Less: current maturities of long-term debt	40.2		30.7		—
Less: borrowings under Revolving Credit Facility (1)	—		—		27.0
Total long-term debt	$	1,101.9	$	1,219.3	$	—


(1)	Borrowings shown for September 8, 2012 were under the Company’s previous revolving credit facility.

On October 9, 2012, the Company completed all conditions precedent for the receipt of funding under a new credit agreement (the “New Credit Agreement”) with a bank syndicate. The New Credit Agreement provided the Company with a $1,100.0 million secured credit facility, consisting of a Term Loan A Facility in an aggregate amount of up to $550.0 million (the “Term Loan A Facility”), a Term Loan B Facility in an aggregate amount of up to $350.0 million (the “Term Loan B Facility” and collectively with the Term Loan A Facility the "Term Loan Facilities") and a Revolving Credit Facility in an aggregate amount of up to $200.0 million (the “Revolving Credit Facility”). The New Credit Agreement also provided the Company with the option to increase the aggregate principal amount of all facilities by up to an additional amount such that the total amount of all of the facilities does not exceed $1,300.0 million. As of September 7, 2013, the Company had no outstanding borrowings under the Revolving Credit Facility and outstanding letters of credit of $3.1 million. As of December 29, 2012, the Company had no outstanding borrowings under the Revolving Credit Facility and outstanding letters of credit of $1.9 million.

As required by the New Credit Agreement, the Company also entered into an interest rate swap with a notional amount of $462.2 million that reduces the Company’s exposure to fluctuations in interest rates on its variable rate debt. This derivative instrument was designated as a cash flow hedge of its variable rate debt.

The Term Loan A Facility and the Revolving Credit Facility have a term of five years, and the Term Loan B Facility has a term of seven years. The interest rates applicable to amounts outstanding under the Term Loan A Facility and to U.S. dollar denominated amounts outstanding under the Revolving Credit Facility will be, at the Company’s option, either (1) the Alternate Base Rate as defined in the New Credit Agreement plus an applicable margin determined by the Company’s Consolidated Leverage Ratio, as defined in the New Credit Agreement, with a range of 0.375% to 1.25%, or (2) the Eurocurrency Rate as defined in the New Credit Agreement plus an applicable margin determined by the Company’s Consolidated Leverage Ratio, as defined in the New Credit Agreement, with a range of 1.375% to 2.25%.

The Revolving Credit Facility includes a $100.0 million foreign currency subfacility under which borrowings may be made, subject to certain conditions, in Canadian dollars, British pounds, euros, Hong Kong dollars, Swedish kronor, Swiss francs and such additional currencies determined in accordance with the New Credit Agreement. The Revolving Credit Facility also includes a $35.0 million swingline subfacility and a $50.0 million letter of credit subfacility.

The obligations of the Company pursuant to the New Credit Agreement are guaranteed by substantially all of the Company’s material domestic subsidiaries and secured by substantially all of the personal and real property of the Company and its material domestic subsidiaries, subject to certain exceptions.

The New Credit Agreement also contains certain affirmative and negative covenants, including covenants that limit the ability of the Company and its Restricted Subsidiaries (as defined in the New Credit Agreement) to, among other things: incur or guarantee indebtedness; incur liens; pay dividends or repurchase stock; enter into transactions with affiliates; consummate asset sales, acquisitions or mergers; prepay certain other indebtedness; or make investments, as well as covenants restricting the activities of certain foreign subsidiaries of the Company that hold intellectual property related assets. Further, the New Credit Agreement requires compliance with the following financial covenants: a maximum Consolidated Leverage Ratio; a maximum Consolidated Secured Leverage Ratio; and a minimum Consolidated Interest Coverage Ratio (in each case as such ratios are defined in the New Credit Agreement). As of September 7, 2013 the Company was in compliance with all such restrictions and financial covenants.

Subsequent to the end of the third fiscal quarter, on October 10, 2013, the Company amended the New Credit Agreement (the "Amendment") and paid down the balance of the Term Loan B Facility to zero while increasing the balance of the Term Loan A Facility to $775.0 million, resulting in a decrease in the applicable interest rate. The Amendment also extended the maturity date of the Term Loan A Facility and the Revolving Credit Facility to October 10, 2018, allowed for incremental facilities that, when combined with the Term Loan A Facility and the Revolving Credit Facility, do not exceed $1,350.0 million in the aggregate, and made certain other changes to the New Credit Agreement. The Amendment also increased the swingline subfacility to $50.0 million under the Revolving Credit Facility.

On October 9, 2012, the Company also issued a total of $375.0 million in senior notes in a private placement offering (the “Notes”). The Notes bear interest at 6.125% and are due in 2020. Related interest payments are due semi-annually. The Notes are guaranteed by substantially all of the Company’s domestic subsidiaries.

For the 12 and 36 weeks ended September 7, 2013, the Company included in interest expense the amortization of deferred financing costs of approximately $1.5 million and $4.6 million, respectively. For the 12 and 36 weeks ended September 8, 2012, the Company included in interest expense the amortization of deferred financing costs of approximately $0.1 million and $0.3 million, respectively.

The Company used the net proceeds from the Notes, together with the borrowings under the Term Loan Facilities and cash on hand, to finance the PLG acquisition, repay any amounts outstanding under prior indebtedness, terminate its previous revolving credit facility and provide for the working capital needs of the Company, including the payment of transaction expenses in connection with the PLG acquisition.

Cash flows from operating activities, along with borrowings under the Revolving Credit Facility, if any, are expected to be sufficient to meet the Company’s working capital needs for the foreseeable future. Any excess cash flows from operating activities are expected to be used to purchase property, plant and equipment, reduce debt, fund growth initiatives, pay dividends or repurchase the Company’s common stock.